S-EPMC7225170 - Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment. - OmicsDI

Unknown

Dataset Information

Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment.

ABSTRACT:

SUBMITTER: Zhang Q

PROVIDER: S-EPMC7225170 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature